Literature DB >> 17761713

The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry.

C Wick, M Egger, S Trelle, P Jüni, M F Fey.   

Abstract

Mesh：

Year:  2007        PMID： 17761713     DOI： 10.1093/annonc/mdm402

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion.

Authors:  Vanessa Boudewyns; Amie C O'Donoghue; Ryan S Paquin; Kathryn J Aikin; Kate Ferriola-Bruckenstein; Victoria M Scott
Journal:  Oncologist       Date:  2021-09-28

2.  Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.

Authors:  Noordin Othman; Agnes I Vitry; Elizabeth E Roughead
Journal:  BMC Public Health       Date:  2010-05-29       Impact factor: 3.295

Review 3.  Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?

Authors:  Courtney Davis
Journal:  Soc Sci Med       Date:  2014-12-02       Impact factor: 4.634
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.